Dosage and administration of anti-ERBB3 antibodies in combination with paclitaxel for treatment of gynecological cancers
PK201200413A0Undetermined Publication Date: 2012-07-25MERRIMACK PHARMACEUTICALS INC +1
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201200413
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2012-06-26
- Publication Date
- 2012-07-25
Need to check novelty before this filing date? Find Prior Art
No text content released.